NCT05040672

Brief Summary

Analyze, through an online questionnaire, the knowledge and practice about the prevention and detection of prostate cancer in male employees of a pharmaceutical company.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
280

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 30, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 10, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 29, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 29, 2022

Completed
Last Updated

August 2, 2022

Status Verified

July 1, 2022

Enrollment Period

1.2 years

First QC Date

August 30, 2021

Last Update Submit

July 29, 2022

Conditions

Prostate Cancer

Outcome Measures

Primary Outcomes (1)

  • Evaluation of Knowledge and Practice About Prostate Cancer e Healthy Habits

    Assess the subjects knowledge and practice in relation to educational campaigns aimed at prostate cancer.All the information wil be collected using a questionnaire previously approved by the ethics committee.

    1 month

Study Arms (1)

Group I

All volunteer male employees of Libbs Pharmaceuticals residing in all Brazilian regions will participate in this research.An online questionnaire will be applied to assess research subjects understanding of prostate cancer and health habits.

Behavioral: questionare online application

Interventions

questionare online applicationBEHAVIORAL

questionare online application

Group I

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

As this is a non-probabilistic or convenience (non-random) sampling, the sample size calculation is not applicable. Today there are about 1500 male employees at Libbs Pharmaceuticals and all will be invited to participate in the survey. Answers obtained from all questionnaires filled in their entirety will be included for analysis.

You may qualify if:

  • Male individuals included in the Libbs workforce;
  • Age 18 years or older;
  • Subjects who agree to participate in the study after reading and signing the Informed Consent Form.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Augusto Figueiredo

São Paulo, 01140050, Brazil

Location

MeSH Terms

Conditions

Prostatic Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 30, 2021

First Posted

September 10, 2021

Study Start

June 1, 2021

Primary Completion

July 29, 2022

Study Completion

July 29, 2022

Last Updated

August 2, 2022

Record last verified: 2022-07

Locations

BR(1)